DEF 14A

Company

Inhibitor Therapeutics, Inc.

Filed

September 17, 2009

Period of Report

October 9, 2009

Accession Number

0001193125-09-193558

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →